India · Delayed Price · Currency is INR Morepen Laboratories Company Description
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India, the United States, and internationally.
The company offers APIs for anti-histaminic, anti-asthmatic, anti-lipemic, anti-hypertensive, anti-diabetic, anti-coagulant, anti-ulcerative, and anti-depressant drugs; and home diagnostic products, such as air purifiers, sphygmomanometers, blood glucose test strips, blood pressure monitors, breathe free vaporizers, stethoscopes, digital thermometers, blood glucose monitors, nebulizers, heat belts, and pulse oximeters.
It also provides OTC and healthcare products, including fever X for fever; Pain X for pain; Fiber-X for constipation; sat isabgol; Acidity X for acidity; Burnol, a first degree/minor burns cream; and formulations for nutrition and probiotics, gastroenterology, antibiotics, gynecology, anti-allergic, and central nervous system, as well as cardiology, diabetology, and nutraceuticals.
The company offers over the counter products under the Dr. Morepen brand name.
Morepen Laboratories Limited was incorporated in 1984 and is based in Gurugram, India.
| Country | India |
| Founded | 1984 |
| Industry | Pharmaceutical Preparations |
| Employees | 1,814 |
| CEO | Sushil Suri |
Contact Details
Address: Tower C, DLF Cyber Park Gurugram, 122016 India | |
| Phone | 91 12 4489 2000 |
| Website | morepen.com |
Stock Details
| Ticker Symbol | 500288 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Sushil Suri | Chief Executive Officer |
| Ajay Sharma | Chief Financial Officer |
| Vivan Prashar | Chief Operating Officer |
| Nishant Doshi | Head of Investor Relations |